Factors | N | Output | Effect size | 95% CI | I2 | P value | P value for Meta-regression |
---|---|---|---|---|---|---|---|
Demographic | |||||||
 Age | 37 | lnOR | 0.98 | 0.53–1.43 | 0.987 | 0.000* |  |
 Gender (Male) | 6 | OR | 2.14 | 0.52–8.77 | 0.922 | 0.290 | 0.243 |
Type of stroke | |||||||
 Intracranial hemorrhage | 25 | OR | 3.79 | 2.77–5.20 | 0.761 | 0.000* | 0.214 |
 Ischemic infarction | 8 | OR fix | 3.18 | 2.40–4.23 | 0.200 | 0.000* | 0.032* |
Clinical manifestation (general) | |||||||
 Headache | 8 | OR fix | 0.22 | 0.17–0.29 | 0.000 | 0.000* | 0.175 |
 Seizure | 14 | OR | 2.74 | 1.76–4.27 | 0.796 | 0.000* |  |
Clinical manifestation (neurological specific) | |||||||
 Focal deficit | 13 | OR fix | 4.72 | 3.86–5.78 | 0.388 | 0.000* | 0.526 |
 Coma | 12 | OR | 11.60 | 6.12–21.98 | 0.854 | 0.000* |  |
 Consciousness disorder | 7 | OR | 7.07 | 4.15–12.04 | 0.740 | 0.000* |  < 0.001* |
 NIHSS | 4 | lnOR | 1.69 | (-)0.09–3.47 | 0.987 | 0.060 |  |
Blood Biomarkers | |||||||
 NLR | 7 | lnOR | 1.72 | 0.96–2.47 | 0.963 | 0.000* | 0.015* |
 Lymphocyte | 5 | cohens'd fix | −0.63 | (-)0.78-(-)0.47 | 0.184 | 0.000* |  |
 D-dimer | 4 | lnOR | 1.34 | 0.87–1.80 | 0.778 | 0.000* |  |
 CRP | 3 | lnOR | 2.99 | (-)0.40–6.37 | 0.991 | 0.080 |  |
Radiology image | |||||||
 Parenchymal lesion | 5 | OR | 4.71 | 1.12–19.84 | 0.900 | 0.030* | 0.379 |
 Deep cerebral venous thrombosis | 8 | OR | 6.30 | 2.92–13.63 | 0.719 | 0.000* | 0.390 |
Complication | |||||||
 Cancer | 6 | OR fix | 3.87 | 2.95–5.07 | 0.424 | 0.000* |  |
 Blood glucose level | 5 | OR | 3.52 | 1.61–7.68 | 0.937 | 0.000* |  |
 Hemoglobin/anemia | 5 | OR | 1.61 | 0.96–2.69 | 0.988 | 0.070 |  |
 Blood pressure | 5 | OR | 7.53 | 0.55–103.77 | 0.984 | 0.130 | 0.051 |